Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
Global Regulatory Systems01:28

Global Regulatory Systems

406
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
406
Ethics in Research01:56

Ethics in Research

25.2K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.2K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

395
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
395
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

297
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
297
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

111
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
111

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

Neurology·2026
Same author

Perceptions of research participation among underrepresented groups: Insights using freelisting methodology.

PloS one·2026
Same author

Barriers to Optimization of Medical Therapy and the Role of Checklist-Based Decision Support in Heart Failure.

Journal of the American Heart Association·2026
Same author

Excise taxes of oral nicotine pouches in the USA.

Tobacco control·2026
Same author

Designing Consent Processes for Research With Older Adults Who May Lack Decisional Capacity: A Guide for Investigators.

Journal of the American Geriatrics Society·2026
Same author

Making the Move to a Learning System of Research Ethics.

The Hastings Center report·2026

Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.7K

Regulatory flexibility for COVID-19 research.

Holly Fernandez Lynch1, Neal W Dickert2, Patricia J Zettler3

  • 1Department of Medical Ethics and Health Policy, Perelman School of Medicine, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.

Journal of Law and the Biosciences
|September 10, 2020
PubMed
Summary

Clinical research during pandemics faces regulatory hurdles. This study proposes flexibility in human subjects protection to balance participant safety with efficient evidence generation for better patient care.

Keywords:
COVID-19emergency researchhuman subjects protectioninformed consentinstitutional review boardprisoners

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

14.9K

Related Experiment Videos

Last Updated: Dec 9, 2025

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

2.7K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

14.9K

Area of Science:

  • Public Health
  • Clinical Research Ethics
  • Regulatory Science

Background:

  • COVID-19 highlighted challenges in clinical research regulations.
  • Existing guidance for pandemic research has limitations.
  • Human subjects protection requirements can impede urgent studies.

Purpose of the Study:

  • Identify specific compliance challenges in pandemic research.
  • Propose regulatory flexibility to address these challenges.
  • Enhance both participant protection and research efficiency.

Main Methods:

  • Analysis of regulatory requirements for human subjects protection.
  • Review of guidance issued during the COVID-19 pandemic.
  • Identification of compliance gaps in key research areas.

Main Results:

  • Specific challenges identified in IRB review, informed consent, emergency research, and research with incarcerated populations.
  • Regulatory flexibility is proposed for these areas.
  • Recommendations aim to streamline oversight while maintaining ethical standards.

Conclusions:

  • Balancing participant protection and research advancement is crucial.
  • Proposed regulatory flexibility can improve clinical research efficiency during pandemics.
  • These recommendations have broader implications for research oversight and participant safety.